I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ducray, François
475
results:
english X
Search for persons
X
Format
Online (475)
Mediatypes
E-Books (8)
Articles (Online) (144)
OpenAccess-fulltext (323)
Sorted by: Relevance
Sorted by: Year
?
1
Olaparib in recurrent isocitrate dehydrogenase mutant high-..:
Esparragosa Vazquez, Ines
;
Sanson, Marc
;
Chinot, Olivier L
...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1093/..
?
2
Marizomib for patients with newly diagnosed glioblastoma: a..:
Roth, Patrick
;
Gorlia, Thierry
;
Reijneveld, Jaap C
...
Neuro-Oncology. , 2024
Link:
https://doi.org/10.1093/..
?
3
TARGET: A phase I/II open-label multicenter study to assess..:
Picca, Alberto
;
Di Stefano, Anna Luisa
;
Savatovsky, Julien
...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1093/..
?
4
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH m..:
Picca, Alberto
;
Touat, Mehdi
;
Belin, Lisa
...
European Journal of Cancer. 202 (2024) - p. 114034 , 2024
Link:
https://doi.org/10.1016/..
?
5
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the..:
Le Rhun, Emilie
;
Gorlia, Thierry
;
Felsberg, Jörg
...
European Journal of Cancer. 198 (2024) - p. 113475 , 2024
Link:
https://doi.org/10.1016/..
?
6
Characteristics of H3K27M-mutant diffuse gliomas with a non..:
Guidara, Souhir
;
Seyve, Antoine
;
Poncet, Delphine
...
Journal of Neuro-Oncology. , 2024
Link:
https://doi.org/10.1007/..
?
7
Repeated blood–brain barrier opening with a nine-emitter im..:
Carpentier, Alexandre
;
Stupp, Roger
;
Sonabend, Adam M.
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
8
Predictors of Progression in a Series of 81 Adult Patients ..:
Garrido, Elisabeth
;
Ngoc, Huy Le
;
Guyotat, Jacques
...
Cancers. 16 (2024) 7 - p. 1261 , 2024
Link:
https://doi.org/10.3390/..
?
9
Corrigendum to "Zotiraciclib (TG02) for newly diagnosed gli..:
Le Rhun, Emilie
;
Gorlia, Thierry
;
Felsberg, Jörg
...
European Journal of Cancer. 204 (2024) - p. 114066 , 2024
Link:
https://doi.org/10.1016/..
?
10
The biological significance of tumor grade, age, enhancemen..:
van den Bent, Martin J
;
French, Pim J
;
Brat, Daniel
...
Neuro-Oncology. , 2024
Link:
https://doi.org/10.1093/..
?
11
Pseudocystic inflammatory demyelinating lesions in multiple..:
Cluse, Florent
;
Fenouil, Tanguy
;
Vukusic, Sandra
...
Multiple Sclerosis Journal. 29 (2023) 10 - p. 1340-1344 , 2023
Link:
https://doi.org/10.1177/..
?
12
LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR ..:
Wen, Patrick
;
Mellinghoff, Ingo
;
van den Bent, Martin
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v310-v311 , 2023
Link:
https://doi.org/10.1093/..
?
13
EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A REL..:
Verreault, Maite
;
Vilchis, Irma Segoviano
;
Rosenberg, Shai
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v237-v237 , 2023
Link:
https://doi.org/10.1093/..
?
14
CTNI-34. ZOTIRACICLIB (TG02) FOR NEWLY DIAGNOSED GLIOBLASTO..:
Rhun, Emilie Le
;
Gorlia, Thierry
;
Felsberg, Jörg
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v81-v82 , 2023
Link:
https://doi.org/10.1093/..
?
15
CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:
Cloughesy, Timothy
;
Mellinghoff, Ingo
;
van den Bent, Martin
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v86-v87 , 2023
Link:
https://doi.org/10.1093/..
1-15